Page last updated: 2024-10-21

isopentenyl pyrophosphate and Multiple Myeloma

isopentenyl pyrophosphate has been researched along with Multiple Myeloma in 3 studies

isopentenyl pyrophosphate: substrate for isopentenyl pyrophosphate isomerase; RN given refers to unlabeled cpd; a nonpeptide mycobacterial antigen that stimulates gamma delta T cells
isopentenyl diphosphate : A prenol phosphate comprising 3-methylbut-3-en-1-ol having an O-diphosphate substituent.

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research Excerpts

ExcerptRelevanceReference
"We have addressed this issue in multiple myeloma (MM), a prototypic disease with several immune dysfunctions that also affect γδ T cells and DC."1.37Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αβ CD8+ T cells, regulatory T cells, and dendritic cells. ( Boccadoro, M; Bosia, A; Canepari, ME; Castella, B; Coscia, M; Fiore, F; Foglietta, M; Massaia, M; Palumbo, A; Pantaleoni, F; Peola, S; Riganti, C, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashihara, E1
Munaka, T1
Kimura, S1
Nakagawa, S1
Nakagawa, Y1
Kanai, M1
Hirai, H1
Abe, H1
Miida, T1
Yamato, S1
Shoji, S1
Maekawa, T1
Castella, B1
Riganti, C1
Fiore, F1
Pantaleoni, F1
Canepari, ME1
Peola, S1
Foglietta, M1
Palumbo, A1
Bosia, A1
Coscia, M1
Boccadoro, M1
Massaia, M1
Lin, YS1
Park, J1
De Schutter, JW1
Huang, XF1
Berghuis, AM1
Sebag, M1
Tsantrizos, YS1

Other Studies

3 other studies available for isopentenyl pyrophosphate and Multiple Myeloma

ArticleYear
Isopentenyl pyrophosphate secreted from Zoledronate-stimulated myeloma cells, activates the chemotaxis of γδT cells.
    Biochemical and biophysical research communications, 2015, Aug-07, Volume: 463, Issue:4

    Topics: Cell Line, Tumor; Chemotaxis, Leukocyte; Culture Media, Conditioned; Diphosphonates; Hemiterpenes; H

2015
Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αβ CD8+ T cells, regulatory T cells, and dendritic cells.
    Journal of immunology (Baltimore, Md. : 1950), 2011, Aug-15, Volume: 187, Issue:4

    Topics: B7-1 Antigen; Bone Density Conservation Agents; CD8-Positive T-Lymphocytes; Cell Communication; Cell

2011
Design and synthesis of active site inhibitors of the human farnesyl pyrophosphate synthase: apoptosis and inhibition of ERK phosphorylation in multiple myeloma cells.
    Journal of medicinal chemistry, 2012, Apr-12, Volume: 55, Issue:7

    Topics: Aminopyridines; Aniline Compounds; Antineoplastic Agents; Apoptosis; Catalytic Domain; Cell Survival

2012